Marathon Asset Management (UK)’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-228,688
Closed -$11.8M – 100
2018
Q1
$11.8M Sell
228,688
-377,820
-62% -$20.2M 0.18% 96
2017
Q4
$32M Sell
606,508
-16,166
-3% -$803K 0.49% 71
2017
Q3
$30.6M Sell
622,674
-4,172
-0.7% -$198K 0.5% 68
2017
Q2
$30.5M Sell
626,846
-3,702
-0.6% -$170K 0.53% 66
2017
Q1
$26.7M Sell
630,548
-26,427
-4% -$1.09M 0.58% 62
2016
Q4
$27.8M Sell
656,975
-11,225
-2% -$458K 0.6% 65
2016
Q3
$29.4M Sell
668,200
-48,454
-7% -$2.17M 0.63% 61
2016
Q2
$31.4M Sell
716,654
-1,389
-0.2% -$59.9K 0.66% 58
2016
Q1
$31.8M Sell
718,043
-1,881
-0.3% -$79.6K 0.7% 54
2015
Q4
$30.3M Sell
719,924
-3,301
-0.5% -$139K 0.68% 57
2015
Q3
$28.3M Sell
723,225
-8,730
-1% -$355K 0.68% 55
2015
Q2
$30.6M Sell
731,955
-4,573
-0.6% -$195K 0.7% 50
2015
Q1
$30.7M Sell
736,528
-21,948
-3% -$848K 0.74% 46
2014
Q4
$28.3M Sell
758,476
-6,496
-0.8% -$234K 0.68% 50
2014
Q3
$26.7M Sell
764,972
-61,689
-7% -$2.13M 0.65% 51
2014
Q2
$27.9M Sell
826,661
-68,596
-8% -$2.29M 0.69% 51
2014
Q1
$31.4M Sell
895,257
-363,150
-29% -$12.7M 0.8% 46
2013
Q4
$45.1M Sell
1,258,407
-324,313
-20% -$10.9M 1.11% 34
2013
Q3
$51.6M Sell
1,582,720
-173,646
-10% -$5.65M 1.25% 32
2013
Q2
$62.7M Buy
+1,756,366
New +$61.1M 1.49% 30

Other funds holding FMS

Marathon Asset Management (UK)'s FMS Position: Q2 2018 in Review

Marathon Asset Management (UK) sold out of Fresenius Medical Care (FMS) in Q2 2018, closing a stake of 228,688 shares — an estimated $11.8M sold.

Marathon Asset Management (UK) first reported a position in FMS in Q2 2013 and held it in 20 quarters. The position peaked at $62.7M in Q2 2013. 225 funds tracked by Wall St. Rank hold FMS as of Q2 2018.

  • Marathon Asset Management (UK) reported no remaining Fresenius Medical Care position as of Q2 2018 after selling out during the quarter.
  • Marathon Asset Management (UK) sold 228,688 Fresenius Medical Care shares in Q2 2018, an estimated $11.8M.
  • Marathon Asset Management (UK) first reported a position in Fresenius Medical Care in Q2 2013 and held it in 20 quarters.
  • Marathon Asset Management (UK)'s Fresenius Medical Care position peaked at $62.7M in Q2 2013.
  • 225 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2018.

Based on Marathon Asset Management (UK)'s 13F filing for Q2 2018, filed 31 Jul 2018.